A public-private partnership model for COVID-19 diagnostics

Affiliations

• ¹ Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands.
• ² Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands.
• ³ InActiv Blue, Beernem, Belgium.
• ⁴ Biogazelle, Zwijnaarde, Belgium.
• ⁵ Department of Medical Microbiology, University Medical Center, Utrecht, the Netherlands.
• ⁶ Tecan labwerx, Tecan Trading AG, Männedorf, Switzerland.
• ⁷ National Screening Laboratory Sanquin, Sanquin Diagnostics, Amsterdam, the Netherlands.
• ⁸ Bodegro B.V, Breda, the Netherlands.
• ⁹ HiFiBio Therapeutics, Saint-Jacques, France.
• ¹⁰ Department of Laboratory Automation, Genmab B.V., Utrecht, the Netherlands.
• ¹¹ Laboratory of Medical Microbiology, Stichting PAMM, Veldhoven, the Netherlands. l.van.der.velden@pamm.nl.
• ¹² Department of Laboratory Automation, Genmab B.V., Utrecht, the Netherlands. mbh@genmab.com.
• ¹³ Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. w.laat@hubrecht.eu.
• ¹⁴ Oncode Institute, Hubrecht Institute-KNAW and University Medical Center Utrecht, Utrecht, the Netherlands. m.tanenbaum@hubrecht.eu.